Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Cumulative Risk of Guillain–Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic

Identifieur interne : 000643 ( Pmc/Curation ); précédent : 000642; suivant : 000644

Cumulative Risk of Guillain–Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic

Auteurs : Claudia Vellozzi ; Shahed Iqbal ; Brock Stewart ; Jerome Tokars ; Frank Destefano

Source :

RBID : PMC:4025712

Abstract

Objectives. We sought to assess risk of Guillain–Barré syndrome (GBS) among influenza A (H1N1) 2009 monovalent (pH1N1) vaccinated and unvaccinated populations at the end of the 2009 pandemic.

Methods. We applied GBS surveillance data from a US population catchment area of 45 million from October 15, 2009, through May 31, 2010. GBS cases meeting Brighton Collaboration criteria were included. We calculated the incidence density ratio (IDR) among pH1N1 vaccinated and unvaccinated populations. We also estimated cumulative GBS risk using life table analysis. Additionally, we used vaccine coverage data and census population estimates to calculate denominators.

Results. There were 392 GBS cases; 64 (16%) occurred after pH1N1vaccination. The vaccinated population had lower average risk (IDR = 0.83, 95% confidence interval = 0.63, 1.08) and lower cumulative risk (6.6 vs 9.2 cases per million persons, P = .012) of GBS.

Conclusions. Our findings suggest that at the end of the influenza season cumulative GBS risk was less among the pH1N1vaccinated than the unvaccinated population, suggesting the benefit of vaccination as it relates to GBS. The observed potential protective effect on GBS attributed to vaccination warrants further study.


Url:
DOI: 10.2105/AJPH.2013.301651
PubMed: 24524517
PubMed Central: 4025712

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:4025712

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Cumulative Risk of Guillain–Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic</title>
<author>
<name sortKey="Vellozzi, Claudia" sort="Vellozzi, Claudia" uniqKey="Vellozzi C" first="Claudia" last="Vellozzi">Claudia Vellozzi</name>
</author>
<author>
<name sortKey="Iqbal, Shahed" sort="Iqbal, Shahed" uniqKey="Iqbal S" first="Shahed" last="Iqbal">Shahed Iqbal</name>
</author>
<author>
<name sortKey="Stewart, Brock" sort="Stewart, Brock" uniqKey="Stewart B" first="Brock" last="Stewart">Brock Stewart</name>
</author>
<author>
<name sortKey="Tokars, Jerome" sort="Tokars, Jerome" uniqKey="Tokars J" first="Jerome" last="Tokars">Jerome Tokars</name>
</author>
<author>
<name sortKey="Destefano, Frank" sort="Destefano, Frank" uniqKey="Destefano F" first="Frank" last="Destefano">Frank Destefano</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">24524517</idno>
<idno type="pmc">4025712</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025712</idno>
<idno type="RBID">PMC:4025712</idno>
<idno type="doi">10.2105/AJPH.2013.301651</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">000643</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000643</idno>
<idno type="wicri:Area/Pmc/Curation">000643</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000643</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Cumulative Risk of Guillain–Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic</title>
<author>
<name sortKey="Vellozzi, Claudia" sort="Vellozzi, Claudia" uniqKey="Vellozzi C" first="Claudia" last="Vellozzi">Claudia Vellozzi</name>
</author>
<author>
<name sortKey="Iqbal, Shahed" sort="Iqbal, Shahed" uniqKey="Iqbal S" first="Shahed" last="Iqbal">Shahed Iqbal</name>
</author>
<author>
<name sortKey="Stewart, Brock" sort="Stewart, Brock" uniqKey="Stewart B" first="Brock" last="Stewart">Brock Stewart</name>
</author>
<author>
<name sortKey="Tokars, Jerome" sort="Tokars, Jerome" uniqKey="Tokars J" first="Jerome" last="Tokars">Jerome Tokars</name>
</author>
<author>
<name sortKey="Destefano, Frank" sort="Destefano, Frank" uniqKey="Destefano F" first="Frank" last="Destefano">Frank Destefano</name>
</author>
</analytic>
<series>
<title level="j">American Journal of Public Health</title>
<idno type="ISSN">0090-0036</idno>
<idno type="eISSN">1541-0048</idno>
<imprint>
<date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<italic>Objectives.</italic>
We sought to assess risk of Guillain–Barré syndrome (GBS) among influenza A (H1N1) 2009 monovalent (pH1N1) vaccinated and unvaccinated populations at the end of the 2009 pandemic.</p>
<p>
<italic>Methods.</italic>
We applied GBS surveillance data from a US population catchment area of 45 million from October 15, 2009, through May 31, 2010. GBS cases meeting Brighton Collaboration criteria were included. We calculated the incidence density ratio (IDR) among pH1N1 vaccinated and unvaccinated populations. We also estimated cumulative GBS risk using life table analysis. Additionally, we used vaccine coverage data and census population estimates to calculate denominators.</p>
<p>
<italic>Results.</italic>
There were 392 GBS cases; 64 (16%) occurred after pH1N1vaccination. The vaccinated population had lower average risk (IDR = 0.83, 95% confidence interval = 0.63, 1.08) and lower cumulative risk (6.6 vs 9.2 cases per million persons,
<italic>P</italic>
 = .012) of GBS.</p>
<p>
<italic>Conclusions.</italic>
Our findings suggest that at the end of the influenza season cumulative GBS risk was less among the pH1N1vaccinated than the unvaccinated population, suggesting the benefit of vaccination as it relates to GBS. The observed potential protective effect on GBS attributed to vaccination warrants further study.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Am J Public Health</journal-id>
<journal-id journal-id-type="iso-abbrev">Am J Public Health</journal-id>
<journal-id journal-id-type="publisher-id">ajph</journal-id>
<journal-title-group>
<journal-title>American Journal of Public Health</journal-title>
</journal-title-group>
<issn pub-type="ppub">0090-0036</issn>
<issn pub-type="epub">1541-0048</issn>
<publisher>
<publisher-name>American Public Health Association</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">24524517</article-id>
<article-id pub-id-type="pmc">4025712</article-id>
<article-id pub-id-type="publisher-id">301651</article-id>
<article-id pub-id-type="doi">10.2105/AJPH.2013.301651</article-id>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Epidemiology</subject>
<subject>Immunization/Vaccines</subject>
<subject>Infectic Health Practice</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Research and Practice</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cumulative Risk of Guillain–Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Vellozzi</surname>
<given-names>Claudia</given-names>
</name>
<degrees>MD, MPH</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Iqbal</surname>
<given-names>Shahed</given-names>
</name>
<degrees>PhD, MBBS, MPH</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stewart</surname>
<given-names>Brock</given-names>
</name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tokars</surname>
<given-names>Jerome</given-names>
</name>
<degrees>MD, MPH</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>DeStefano</surname>
<given-names>Frank</given-names>
</name>
<degrees>MD, MPH</degrees>
</contrib>
<aff>Claudia Vellozzi, Shahed Iqbal, Brock Stewart, and Frank DeStefano are with the Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA. Jerome Tokars is with the Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention.</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence should be sent to Claudia Vellozzi, MD, MPH, Immunization Safety Office, Centers for Disease Control and Prevention, 1600 Clifton Rd NE; MS d-26, Atlanta, GA 30333 (email:
<email>Bno1@cdc.gov</email>
). Reprints can be ordered at
<ext-link ext-link-type="uri" xlink:href="http://www.ajph.org">http://www.ajph.org</ext-link>
by clicking the “Reprints” link.</corresp>
<fn>
<p>
<bold>Note.</bold>
The findings and conclusions are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention.</p>
</fn>
<fn>
<p>
<bold>Contributors</bold>
</p>
<p>Claudia Vellozzi contributed to the conceptualization, design, interpretation of data, and drafting and revisions of the article. Shahed Iqbal contributed to the design, analysis, interpretation of data, and drafting of the article. Brock Stewart contributed to the analysis and revisions of the article. Jerome Tokars contributed to the interpretation of data and revisions of the article. Frank DeStefano contributed to the conceptualization, design, interpretation of data, and revisions of the article. All authors approved the final version to be published.</p>
</fn>
<fn>
<p>Peer Reviewed</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<month>4</month>
<year>2014</year>
</pub-date>
<pub-date pub-type="epub">
<month>4</month>
<year>2014</year>
</pub-date>
<volume>104</volume>
<issue>4</issue>
<fpage>696</fpage>
<lpage>701</lpage>
<history>
<date date-type="accepted">
<day>4</day>
<month>9</month>
<year>2013</year>
</date>
</history>
<permissions>
<copyright-statement>© American Public Health Association 2014</copyright-statement>
<copyright-year>2014</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:type="simple" xlink:href="AJPH.2013.301651.pdf"></self-uri>
<abstract>
<p>
<italic>Objectives.</italic>
We sought to assess risk of Guillain–Barré syndrome (GBS) among influenza A (H1N1) 2009 monovalent (pH1N1) vaccinated and unvaccinated populations at the end of the 2009 pandemic.</p>
<p>
<italic>Methods.</italic>
We applied GBS surveillance data from a US population catchment area of 45 million from October 15, 2009, through May 31, 2010. GBS cases meeting Brighton Collaboration criteria were included. We calculated the incidence density ratio (IDR) among pH1N1 vaccinated and unvaccinated populations. We also estimated cumulative GBS risk using life table analysis. Additionally, we used vaccine coverage data and census population estimates to calculate denominators.</p>
<p>
<italic>Results.</italic>
There were 392 GBS cases; 64 (16%) occurred after pH1N1vaccination. The vaccinated population had lower average risk (IDR = 0.83, 95% confidence interval = 0.63, 1.08) and lower cumulative risk (6.6 vs 9.2 cases per million persons,
<italic>P</italic>
 = .012) of GBS.</p>
<p>
<italic>Conclusions.</italic>
Our findings suggest that at the end of the influenza season cumulative GBS risk was less among the pH1N1vaccinated than the unvaccinated population, suggesting the benefit of vaccination as it relates to GBS. The observed potential protective effect on GBS attributed to vaccination warrants further study.</p>
</abstract>
<counts>
<page-count count="6"></page-count>
</counts>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000643 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 000643 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Pmc
   |étape=   Curation
   |type=    RBID
   |clé=     PMC:4025712
   |texte=   Cumulative Risk of Guillain–Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i   -Sk "pubmed:24524517" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a PandemieGrippaleV1 

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021